Loading…
Dividends declared (per SOCE filings): FY2022 24,397 · FY2023 17,641 · FY2024 8,335 — 3-yr total 50,372
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company is a pharmaceutical company engaged in purchasing, processing, warehousing and wholesale distribution of pharmaceutical products across multiple countries.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 7,278 | 9,189 | 16,604 | 15,797 | 30,017 | 23,774 | 17,039 | 8,348 | +2.0% |
| Net Cash used in Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67 | |
| Net Cash from Financing Activities | 0 | 10,273 | 17,031 | 15,847 | 29,122 | 24,397 | 17,641 | 8,335 | -3.4% |
| Net Change in Cash (before FX) | 7,278 | 1,084 | 427 | 50 | 894 | 623 | 601 | 81 | -47.4% |
| Effect of FX on Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 80 | |
| Net Change in Cash (incl. FX) | 7,278 | 1,084 | 427 | 50 | 894 | 623 | 601 | 1 | nmf |
| Cash at Beginning of Year | 0 | 1,896 | 812 | 384 | 334 | 1,228 | 606 | 5 | nmf |
| Cash at End of Year | 0 | 812 | 384 | 334 | 1,228 | 606 | 5 | 5 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →